Skip to content

    USANA HEALTH SCIENCES (USNA) stock price & financials

    View USNA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance56.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26Trend
    EarningsRevenue
    $200.22M
    $213.61M
    $249.54M
    $235.85M
    $213.67M
    +6.7%
    $226.20M
    +5.9%
    $250.22M
    +0.3%
    $223.27M
    -5.3%
    Stable
    Operating Profit
    $15.60M
    $8.21M
    $15.67M
    $16.72M
    $1.22M
    -92.2%
    $3.82M
    -53.5%
    $13.87M
    -11.5%
    -$20.00M
    -219.6%
    Weakening
    Net Profit
    $10.61M
    $4.45M
    $9.40M
    $9.65M
    -$6.52M
    -161.5%
    -$1.77M
    -139.9%
    $7.51M
    -20.1%
    -$21.38M
    -321.5%
    Weakening
    EPS
    $0.56
    $0.49
    $0.52
    $-0.36
    -164.3%
    $0.41
    -16.3%
    $-1.16
    -323.1%
    Weakening
    Other Income
    $3.01M
    $2.22M
    $1.07M
    $2.10M
    $570.0K
    -81.0%
    $358.0K
    -83.9%
    $1.59M
    +49.0%
    $1.10M
    -47.8%
    Weakening
    Interest
    $49.0K
    $129.0K
    $411.0K
    $259.0K
    $49.0K
    +0.0%
    $123.0K
    -4.7%
    $240.0K
    -41.6%
    $0
    -100.0%
    Weakening
    Depreciation
    Profit before Tax
    $18.61M
    $10.43M
    $16.74M
    $18.82M
    $1.79M
    -90.4%
    $4.18M
    -59.9%
    $15.46M
    -7.6%
    -$18.90M
    -200.4%
    Weakening
    MarginsOPM
    7.8%
    3.8%
    6.3%
    7.1%
    0.6%
    -92.7%
    1.7%
    -56.0%
    5.5%
    -11.8%
    -9.0%
    -226.4%
    Weakening
    Tax
    43.0%
    57.0%
    44.5%
    44.5%
    471.4%
    +996.2%
    138.2%
    +142.4%
    55.0%
    +23.6%
    -47.9%
    -207.6%
    Weakening
    ReturnsROIC
    2.3%
    1.0%
    2.1%
    2.1%
    -1.4%
    -161.5%
    -0.4%
    -139.9%
    1.7%
    -20.1%
    -4.7%
    -321.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY21FY22FY22FY23FY24FY26TTM
    AssetsCash & Equivalents$214.33M$234.83M$311.92M$239.83M$288.42M$330.42M$181.77M$158.38M$168.56M
    Short-Term Investments
    Total Current Assets$392.33M$329.28M$425.29M$365.12M$384.38M$417.75M$279.19M$288.40M$281.07M
    Net PP&E$92.03M$126.50M$100.44M$125.57M$117.77M$117.48M$115.74M$117.34M$94.27M
    Goodwill$16.82M$16.64M$17.37M$17.67M$17.37M$17.10M$144.17M$137.96M$109.14M
    Intangibles$31.81M$29.84M$30.80M$30.44M$32.43M$29.92M$151.82M$133.15M$124.61M
    Total Assets$554.46M$516.93M$640.89M$577.74M$596.55M$632.76M$748.19M$742.91M$703.21M
    LiabilitiesTotal Current Liabilities$148.69M$136.10M$168.07M$160.79M$143.83M$118.84M$139.63M$128.56M$105.67M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$17.27M$10.21M$7.68M$5.14M$10.19M$12.31M
    Total Liabilities$163.32M$165.22M$199.24M$182.62M$162.08M$135.56M$161.86M$156.64M$132.24M
    EquityCommon Stock & APIC$24.0K$22.0K$21.0K$19.0K$19.0K$19.0K$19.0K$18.0K$18.0K
    Retained Earnings$329.50M$306.15M$382.79M$344.64M$391.64M$445.22M$478.94M$465.72M$451.85M
    Total Equity$391.15M$351.71M$441.65M$395.12M$434.47M$497.20M$532.11M$533.10M$526.31M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY21FY22FY22FY23FY24FY26TTM
    ActivitiesCash from Operating$152.12M$126.73M$160.40M$121.23M$103.90M$70.64M$60.99M$22.35M$27.73M
    Cash from Investing-$69.00M$47.49M-$33.96M-$14.19M-$12.37M-$11.97M-$213.09M-$10.13M-$8.74M
    Cash from Financing-$105.28M-$152.05M-$59.44M-$181.41M-$30.09M-$14.24M$9.55M-$40.60M-$5.19M
    SummaryCapital Expenditure-$11.43M-$16.57M-$15.09M-$12.76M-$10.40M-$14.49M-$10.07M-$13.82M-$11.79M
    Free Cash Flow$140.69M$110.16M$145.31M$108.46M$93.50M$56.15M$50.92M$8.53M$15.93M
    FCF Margin11.8%10.4%12.8%9.1%9.4%6.1%6.0%0.9%1.7%

    Ratios